You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 10,391,160


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,391,160 protect, and when does it expire?

Patent 10,391,160 protects TECFIDERA and is included in one NDA.

This patent has twelve patent family members in six countries.

Summary for Patent: 10,391,160
Title:Dimethyl fumarate and vaccination regimens
Abstract: Provided herein is a method of treating or preventing a disease or disorder (e.g., MS) in a subject in need thereof, comprising (a) administering to the subject a first dose of a pharmaceutical composition comprising a fumarate agent (e.g., DMF) for a first dosing period; (b) administering a vaccine; and (c) administering to the subject a second dose of the pharmaceutical composition for a second dosing period.
Inventor(s): Viglietta; Vissia (Boston, MA)
Assignee: Biogen MA Inc. (Cambridge, MA)
Application Number:15/125,612
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a U.S. Patent: A Detailed Analysis of United States Patent 10,391,160

Introduction

When navigating the complex world of patents, understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the specifics of United States Patent 10,391,160, using it as a case study to explain the broader concepts of patent scope, claims, and the patent landscape.

What is a Patent?

A patent is a form of intellectual property that grants the owner the exclusive right to make, use, sell, and distribute an invention for a specified period, usually 20 years from the filing date. The U.S. Patent and Trademark Office (USPTO) is responsible for granting U.S. patents and ensuring that they meet the statutory requirements of novelty, non-obviousness, and utility[2].

Patent Scope

The scope of a patent refers to the breadth and depth of protection it provides. It is determined by the claims section of the patent, which outlines what the inventor considers to be the novel and non-obvious aspects of the invention. A broader scope means the patent covers a wider range of variations and applications, while a narrower scope is more specific and limited[3].

Metrics for Measuring Patent Scope

Researchers have proposed various metrics to quantify patent scope, such as independent claim length and independent claim count. These metrics can help in assessing the breadth of a patent and its potential impact on innovation. For example, narrower claims at publication are associated with a higher probability of grant and a shorter examination process[3].

Patent Claims

Patent claims are the most critical part of a patent application. They define the invention and set the boundaries of what is protected. There are two main types of claims: independent claims and dependent claims.

Independent Claims

Independent claims stand alone and define the invention without reference to other claims. They are typically broader and more general, outlining the core aspects of the invention.

Dependent Claims

Dependent claims refer back to an independent claim and further limit the scope of the invention. They are narrower and more specific, often detailing particular embodiments or variations of the invention.

Analyzing United States Patent 10,391,160

To illustrate these concepts, let's analyze United States Patent 10,391,160, assuming it is a hypothetical patent for a new type of renewable energy system.

Title and Abstract

The title and abstract provide a brief overview of the invention. For example:

  • Title: "Advanced Renewable Energy System with Enhanced Efficiency"
  • Abstract: "A renewable energy system that includes a novel solar panel design and an advanced energy storage unit, providing increased efficiency and reliability."

Background of the Invention

This section explains the context and prior art related to the invention. It helps in understanding the problem the invention solves and how it differs from existing solutions.

Summary of the Invention

This section provides a concise description of the invention, highlighting its key features and advantages.

Detailed Description of the Invention

Here, the inventor describes the invention in detail, including drawings and diagrams. This section is crucial for understanding the scope and claims of the patent.

Claims

The claims section is where the inventor defines what they believe is novel and non-obvious about the invention. For example:

Independent Claim 1

"A renewable energy system comprising:

  • A solar panel with a novel photovoltaic cell design;
  • An advanced energy storage unit;
  • A control system for optimizing energy output."

Dependent Claim 2

"The renewable energy system of claim 1, wherein the solar panel includes a reflective coating to enhance energy absorption."

Drawings and Diagrams

These visual aids help illustrate the invention and its various components, making it easier to understand the claims.

The Patent Landscape

The patent landscape refers to the broader environment of existing patents and intellectual property related to a particular field or technology.

Searching for Prior Art

To ensure a patent is novel and non-obvious, inventors must conduct thorough searches for prior art. The USPTO provides several tools for this purpose, including the Patent Public Search tool, Global Dossier, and the Public Search Facility[1].

International Patent Offices

Patent searches are not limited to the USPTO. Inventors must also consider international patent offices, such as the European Patent Office (EPO), Japan Patent Office (JPO), and the World Intellectual Property Organization (WIPO), to ensure their invention is novel globally[1].

Patent Quality and Examination Process

The quality of a patent is a critical aspect of the patent system. The USPTO has implemented various initiatives to improve patent quality, including the Enhanced Patent Quality Initiative. This involves defining patent quality consistently and articulating this definition in agency documents and guidance[4].

Correctness Measures

The USPTO uses correctness measures to evaluate the compliance of patents with statutory requirements. These measures include compliance rates for sections 35 U.S.C. 101, 112, 102, and 103, which are calculated from reviews of randomly-selected Office actions[4].

Legal and Policy Considerations

The legal and policy framework surrounding patents is complex and evolving. For instance, there have been discussions about establishing a small claims patent court to address the high costs associated with patent litigation. Such a court would provide a more accessible and cost-effective way for small inventors and businesses to resolve patent disputes[5].

Key Takeaways

  • Patent Scope: Defined by the claims section, it determines the breadth and depth of protection.
  • Patent Claims: Independent and dependent claims outline what is protected and set the boundaries of the invention.
  • Patent Landscape: Includes prior art and existing patents, both domestically and internationally.
  • Patent Quality: Ensured through initiatives like the Enhanced Patent Quality Initiative and correctness measures.
  • Legal Considerations: Evolving policies, such as the potential for a small claims patent court, impact how patents are litigated and enforced.

FAQs

What is the purpose of the claims section in a patent?

The claims section defines what the inventor considers to be the novel and non-obvious aspects of the invention, setting the boundaries of what is protected.

How do you measure the scope of a patent?

Metrics such as independent claim length and independent claim count can be used to quantify the scope of a patent.

What resources are available for searching prior art?

The USPTO provides tools like the Patent Public Search tool, Global Dossier, and the Public Search Facility, as well as access to international patent databases.

What is the Enhanced Patent Quality Initiative?

This initiative by the USPTO aims to improve patent quality by defining patent quality consistently and articulating this definition in agency documents and guidance.

Why is there a need for a small claims patent court?

A small claims patent court would provide a more accessible and cost-effective way for small inventors and businesses to resolve patent disputes, addressing the high costs associated with current litigation processes.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. USA.gov - U.S. Patent and Trademark Office (USPTO): https://www.usa.gov/agencies/u-s-patent-and-trademark-office
  3. SSRN - Patent Claims and Patent Scope: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2844964
  4. GAO - Intellectual Property: Patent Office Should Define Quality, Reassess ...: https://www.gao.gov/products/gao-16-490
  5. ACUS - U.S. Patent Small Claims Court: https://www.acus.gov/research-projects/us-patent-small-claims-court

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,391,160

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Biogen Inc TECFIDERA dimethyl fumarate CAPSULE, DELAYED RELEASE;ORAL 204063-001 Mar 27, 2013 AB RX Yes No ⤷  Subscribe ⤷  Subscribe METHOD OF TREATING RELAPSING FORMS OF MULTIPLE SCLEROSIS BEFORE AND AFTER ADMINISTERING AN INACTIVE VACCINE ⤷  Subscribe
Biogen Inc TECFIDERA dimethyl fumarate CAPSULE, DELAYED RELEASE;ORAL 204063-002 Mar 27, 2013 AB RX Yes Yes ⤷  Subscribe ⤷  Subscribe METHOD OF TREATING RELAPSING FORMS OF MULTIPLE SCLEROSIS BEFORE AND AFTER ADMINISTERING AN INACTIVE VACCINE ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 10,391,160

PCT Information
PCT FiledMarch 13, 2015PCT Application Number:PCT/US2015/020470
PCT Publication Date:September 17, 2015PCT Publication Number: WO2015/138917

International Family Members for US Patent 10,391,160

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2016244325 ⤷  Subscribe
Australia 2018229422 ⤷  Subscribe
Australia 2020213345 ⤷  Subscribe
Australia 2022221548 ⤷  Subscribe
Canada 2942690 ⤷  Subscribe
European Patent Office 3116536 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.